These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma. Ishikawa H, Sakurai H, Hasegawa M, Mitsuhashi N, Takahashi M, Masuda N, Nakajima M, Kitamoto Y, Saitoh J, Nakano T. Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):513-21. PubMed ID: 15380586 [Abstract] [Full Text] [Related]
6. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Birner P, Schindl M, Obermair A, Breitenecker G, Oberhuber G. Clin Cancer Res; 2001 Jun 01; 7(6):1661-8. PubMed ID: 11410504 [Abstract] [Full Text] [Related]
11. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential. Cohen NA, Lai SY, Ziober AF, Ziober BL. Laryngoscope; 2004 Mar 01; 114(3):418-23. PubMed ID: 15091212 [Abstract] [Full Text] [Related]
16. Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity to chemoradiotherapy in advanced esophageal squamous cell carcinoma. Fukuchi M, Fukai Y, Sohda M, Miyazaki T, Nakajima M, Inose T, Tanaka N, Tsukada K, Kato H, Kuwano H. Oncol Rep; 2009 Apr 01; 21(4):853-9. PubMed ID: 19287979 [Abstract] [Full Text] [Related]
19. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, Allasia C, Bonnier P, Charpin C. Int J Cancer; 2005 Sep 20; 116(5):734-9. PubMed ID: 15849727 [Abstract] [Full Text] [Related]